关键数据
68.575今开
68.760最高
10.18K成交量
270.83市盈率 TTM
10.82市盈率动
--股息TTM
0.01%换手率
68.640昨收
66.000最低
688.52K成交额
亏损市盈率静
30.89市净率
0.00%股息率 TTM
7.09%ROA
93.61052周最高
0.02量比
-130.39M净利润
88.93M总股本
0.2502每股收益TTM
0.41Beta
28.18%ROE
21.15052周最低
4.02%振幅
93.27%毛利率
6.03B总市值
-0.87回报/风险
4.11%风险率

即将为您带来更多新闻,敬请期待。。。
Liquidia Corp评分
0.01与上次评分对比预测8.22
财务诊断9.10
技术分析3.68
公司估值6.59
机构认同度7.00
风险评估6.44
分析师评级
买入评级
104.320目标均价
+55.98%涨幅空间
Liquidia Corp 最新财报电话会记录
Liquidia (LQDA) 2026年第二季度业绩电话会议:YUTREPIA销售额增长31%
Liquidia 的 2026 年第二季度业绩电话会议涵盖了 YUTREPIA 达 1.704 亿美元的销售额、31% 的季度增长、利润上升、管线支出及其 2027 年目标。
财务指标
货币: USD

由于公司未披露,未能获取相关数据
货币: USD

由于公司未披露,未能获取相关数据
Liquidia Corp 简介
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operate through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.
行业药品
公司代码LQDA
员工数量157
国家United States of America
持股情况
| 持股股东 | 占比 |
|---|
| Farallon Capital Management, L.L.C. | 9.73% |
|---|
| Caligan Partners, LP | 9.13% |
|---|
| Manning (Paul B.) | 6.18% |
|---|
| BlackRock Institutional Trust Company, N.A. | 5.33% |
|---|
| 股东类型 | 占比 |
|---|
| Hedge Fund | 32.61% |
|---|
| Investment Advisor | 20.58% |
|---|
| Investment Advisor/Hedge Fund | 10.64% |
|---|
| Individual Investor | 10.32% |
|---|
常见问题
Liquidia Corp(LQDA)的当前股价是多少?
Liquidia Corp(LQDA)的当前股价是 68.64。
Liquidia Corp股票的52周最高点是多少?
Liquidia Corp股票的52周最高点是93.61。
Liquidia Corp股票的52周最低点是多少?
Liquidia Corp股票的52周最低点是21.15。
现在Liquidia Corp(LQDA)的股票是买入、持有还是卖出?
根据分析师评级,Liquidia Corp(LQDA)的总体评级为买入,目标价格为104.32。
Liquidia Corp(LQDA)股票的每股收益(EPS TTM)是多少
Liquidia Corp(LQDA)股票的每股收益(EPS TTM)是0.25。